Chemoembolization, Therapeutic
"Chemoembolization, Therapeutic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Administration of antineoplastic agents together with an embolizing vehicle. This allows slow release of the agent as well as obstruction of the blood supply to the neoplasm.
MeSH Number(s)
E02.520.360.150
E02.926.500.150
Concept/Terms
Chemoembolization, Therapeutic- Chemoembolization, Therapeutic
- Therapeutic Chemoembolization
- Chemoembolizations, Therapeutic
- Therapeutic Chemoembolizations
Below are MeSH descriptors whose meaning is more general than "Chemoembolization, Therapeutic".
Below are MeSH descriptors whose meaning is more specific than "Chemoembolization, Therapeutic".
This graph shows the total number of publications written about "Chemoembolization, Therapeutic" by people in Harvard Catalyst Profiles by year, and whether "Chemoembolization, Therapeutic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 3 | 0 | 3 |
1995 | 2 | 0 | 2 |
1996 | 1 | 1 | 2 |
1998 | 1 | 0 | 1 |
1999 | 4 | 1 | 5 |
2000 | 3 | 1 | 4 |
2001 | 3 | 0 | 3 |
2002 | 1 | 1 | 2 |
2004 | 1 | 1 | 2 |
2006 | 2 | 2 | 4 |
2008 | 2 | 2 | 4 |
2009 | 2 | 0 | 2 |
2011 | 3 | 2 | 5 |
2012 | 4 | 0 | 4 |
2013 | 5 | 2 | 7 |
2014 | 5 | 0 | 5 |
2015 | 2 | 0 | 2 |
2016 | 6 | 0 | 6 |
2017 | 2 | 3 | 5 |
2018 | 5 | 0 | 5 |
2019 | 6 | 2 | 8 |
2020 | 4 | 2 | 6 |
2021 | 5 | 1 | 6 |
2022 | 3 | 0 | 3 |
2023 | 4 | 0 | 4 |
Below are the most recent publications written about "Chemoembolization, Therapeutic" by people in Profiles.
-
Treatment modalities to manage hepatocellular carcinoma patients with portal vein thrombosis: a systematic review and meta-analysis. Ann Palliat Med. 2023 Nov; 12(6):1165-1174.
-
Combination transarterial chemoembolization and microwave ablation vs. microwave ablation monotherapy for hepatocellular carcinomas greater than 3 cm: a comparative study. Diagn Interv Radiol. 2023 11 07; 29(6):805-812.
-
Stage migration as a surrogate of survival in hepatocellular carcinoma treated with transarterial chemoembolization. Hepatol Commun. 2023 04 01; 7(4).
-
A novel method for predicting hepatocellular carcinoma response to chemoembolization using an intraprocedural CT hepatic arteriography-based enhancement mapping: a proof-of-concept analysis. Eur Radiol Exp. 2023 01 30; 7(1):4.
-
Image-Guided Percutaneous and Transarterial Therapies for Primary and Metastatic Lung Cancer. Technol Cancer Res Treat. 2023 Jan-Dec; 22:15330338231164193.
-
Factors Associated With Complete Pathologic Necrosis of Hepatocellular Carcinoma on Explant Evaluation After Locoregional Therapy: A National Analysis Using the UNOS Database. AJR Am J Roentgenol. 2023 05; 220(5):727-735.
-
Metachronous double-hit by transarterial chemoembolisation (TACE) with fotemustine inducing dysplasia-like atypia in the gallbladder and stomach-A diagnostic pitfall. Histopathology. 2022 07; 81(1):128-130.
-
Comparing treatment modalities for hepatocellular carcinoma: the value of network meta-analyses. Acta Oncol. 2022 04; 61(4):495.
-
Conversion to resection post radioembolization in patients with HCC: recommendations from a multidisciplinary working group. HPB (Oxford). 2022 07; 24(7):1007-1018.
-
Stereotactic body radiation therapy for primary liver tumors: An effective liver-directed therapy in the toolbox. Cancer. 2022 03 01; 128(5):956-965.